Content ; Assistive Gizmos for Rheumatoid Osteoarthritis ; You’lso are an essential voice on your own health care group. For individuals who’re also for the a treatment you to isn’t letting you, talk right up. ; Advantage, Wozniacki: Golf star for the taking charges away from lifetime that have RA
369 Comparative effectiveness of JAK inhibitors and biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis Soo-Kyung Cho 1 , Hyoungyoung Kim 1 , Yeo-Jin Song 1...
My heart breaks as I read emails and messages people send me about Rheumatoid Arthritis. Diagnosis is a common theme: “Do I have RA?” “Does my husband have
Interactions and perceptions of patients with rheumatoid arthritis participating in an online support group
1 Temporal and regional variation in the use of biologic and targeted synthetic DMARDs for rheumatoid arthritis: a nationwide cohort study Mark D Russell1, Zijing Yang1, Niamh Dooley1, Mark...
Original research Validity and reliability of the EULAR instrument RAID.7 as a tool to assess individual domains of impact of disease in rheumatoid arthritis: a cross-sectional study of 671...
Published on 9.2.2015 in Vol 4, No 1 (2015): Jan-Mar Development of a Web-Based and Mobile App to Support Physical Activity in Individuals With Rheumatoid Arthritis: Results From the Second...
doi:10.1136/ard-2022-223356 Recommendation EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease- modifying antirheumatic drugs: 2022 update...
Josef S Smolen ; Robert B M Landewé ; Andreas Kerschbaumer1 ; Alexandre Sepriano ; Roberto Caporali ; Christopher John Edwards ; Kimme L Hyrich ; Janet E Pope ; Savia de Souza
This question was recently posted on our Facebook page and it’s one most patients ask at some point. Initiating Biologic therapy is a decision that is obviously made together with your doctor. Here are some factors in this important decision. The purpose of the recommendations appears to be improved care. Remember last February the ACR reported that “Substantial numbers of RA patients with active disease did not receive care consistent with the current ACR treatment recommendations,” Arthr...